Progress in the study of antibody-drug conjugates for the treatment of cervical cancer

Cervical cancer is the second most prevalent malignancy affecting women’s health globally, and the number of morbidity and mortality from cervical cancer continues to rise worldwide. The 5-year survival rate of patients with recurrent or metastatic cervical cancer is significantly reduced, and exist...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Congcong Zhai, Yan Cui, Ling Guo, Cixiang Chen, Yanfang Song, Jinghua Zhong, Yili Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-06-01
Subjects:	antibody-drug conjugates cervical cancer targeted therapy clinical research drug development
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1395784/full